MACM
Search documents
清泉股份创业板IPO获受理 拟募资4.92亿元
Zheng Quan Shi Bao Wang· 2025-12-30 07:46
Core Viewpoint - Jiangsu Qingquan Chemical Co., Ltd. (referred to as "Qingquan") is advancing its IPO on the ChiNext board, aiming to raise 492 million yuan for various projects [1] Company Overview - Qingquan specializes in the R&D, production, and sales of specialty fine chemicals and high-performance polymer materials, recognized as a national-level "little giant" enterprise focusing on specialized technologies [3] - The company has developed a product matrix that includes new material monomers, green solvents, pharmaceutical and pesticide intermediates, and specialty polymer materials, with applications in aerospace, wind power, automotive, electronics, medical devices, chemicals, pharmaceuticals, and pesticides [3] - Qingquan is one of the early adopters in China to develop non-grain biomass-based raw materials, specifically furfural, breaking the traditional reliance on petroleum-based products [3] Technical Capabilities - Qingquan is recognized for its large-scale application of high-pressure catalytic hydrogenation technology in the fine chemical sector and has been designated as a "High-Pressure Catalytic Hydrogenation Engineering Technology Research Center" by the Jiangsu Provincial Department of Science and Technology [4] - The company has achieved international advanced levels in the development and industrialization of selective catalytic hydrogenation technology for cyclic specialty monomers, with its six-membered aromatic ring hydrogenation catalyst and process being internationally leading [4] - Qingquan's core products, MACM and 2-MeTHF, hold approximately 28% and 19% of the global market share, respectively, indicating a strong competitive position in the industry [4] Financial Performance - From 2022 to the first half of 2025, Qingquan's revenue is projected to grow from 687 million yuan to 797 million yuan, with net profits increasing from 53 million yuan to 99 million yuan [5] - The funds raised from the IPO will be allocated to projects including the technical transformation of MACM production, the production of furfural, tetrahydrofuran, and the establishment of a research and development center [5]